Lactose (India) Ltd. Stock Analysis 524202.BO

Lactose India Ltd. engages in manufacturing of pharmaceutical and other pharmaceutical products. The company is headquartered in Mumbai, Gujarat and currently employs 140 full-time employees. The firm is engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products. The firm specializes in the manufacturing of excipients (lactose/liquid color coatings), lactulose, solid dosage forms and liquid dosage forms. The company specializes in manufacturing of lactose monohydrate IP/BP/EP/USP-NF grades. The Company’s lactose products include Formulac 200M, Formulac 80M, Formulac 100M, Formulac 325M, Formulac DC60, Formulac 450M, Formulac 314M and Formulac DC2050. The company is also engaged in the manufacturing of disaccharide lactulose, a versatile bulk API. Disaccharide Lactulose (galacto-fructose) is synthesized from lactose (galacto-glucose) by isomerization of glucose to fructose. Lactulose is used in the treatment of constipation, hepatitis, encephalopathy, intestinal microflora, dental care, diabetes, chronic liver disease and as an effective prebiotic.